Federico Turreni
Research Subjects
Federico Turreni has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Massimo Sassara
6 shared publicationsAntonio Castro
Cardiology Unit Sandro Pertini Hospital Rome Italy
4 shared publicationsAugusto Achilli
Belcolle Hospital, Viterbo, Italy
4 shared publicationsLuigi Padeletti
Department Heart and Vessels, University of Florence, Italy
4 shared publicationsAndrea Colella
Arrhythmia Unit Careggi University Hospital Florence Italy
3 shared publicationsGiuseppe Ricciardi
Department Heart and Vessels, University of Florence, Italy
3 shared publications
Latest Publications
- 27 October 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Late Obesity‐Driven Subcutaneous ICD Geometric Failure: Salvage With Sub‐Serratus Generator Repositioning
S‐ICD efficacy depends on extracardiac shock vector geometry. We report late obesity‐associated geometric deterioration after substantial weight gain. Rising shock impedance prompted reassessment at generator replacement, revealing pocket dehiscence, adipose interposition, and generator superficialization. Because fibrosis precluded parasternal lead mobilization by simple traction, sub‐serratus generator repositioning improved the PRAETORIAN score and shock impedance. Despite a subsequent rise to 130 Ω, defibrillation succeeded with a 65 J shock. S‐ICD geometry should be considered dynamic, particularly after major changes in body habitus.
- 27 October 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Late Obesity‐Driven Subcutaneous ICD Geometric Failure: Salvage With Sub‐Serratus Generator Repositioning
S‐ICD efficacy depends on extracardiac shock vector geometry. We report late obesity‐associated geometric deterioration after substantial weight gain. Rising shock impedance prompted reassessment at generator replacement, revealing pocket dehiscence, adipose interposition, and generator superficialization. Because fibrosis precluded parasternal lead mobilization by simple traction, sub‐serratus generator repositioning improved the PRAETORIAN score and shock impedance. Despite a subsequent rise to 130 Ω, defibrillation succeeded with a 65 J shock. S‐ICD geometry should be considered dynamic, particularly after major changes in body habitus.
- 2 June 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (7) , 1577-1587
Timing of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: Evidence, Mechanisms, and the Emerging Role of Timely ICD‐Guided Intervention
Background: The optimal timing of catheter ablation for ventricular tachycardia (VT) in ischemic cardiomyopathy remains uncertain, with strategies ranging from prophylactic intervention to delayed treatment after recurrent arrhythmia. Increasing evidence suggests that the timing of ablation may critically influence both arrhythmic and clinical outcomes. Objective: To synthesize contemporary evidence on VT ablation timing and to examine the mechanistic and clinical rationale supporting a timing‐oriented therapeutic framework. Methods: We performed a structured narrative review of randomized trials, observational studies, and mechanistic investigations evaluating different ablation strategies, including prophylactic, early, and ICD‐guided approaches. Particular emphasis was placed on integrating clinical outcomes with experimental and imaging data on post‐infarct substrate evolution. Results: Prophylactic ablation reduces arrhythmic burden but has not demonstrated consistent survival benefit. Early ablation strategies improve procedural outcomes but are limited by heterogeneous definitions and inconsistent prognostic impact. By contrast, a timely ICD‐guided approach—based on the first device‐verified arrhythmic event—has demonstrated consistent reductions in VT recurrence and ICD therapies, with emerging but heterogeneous signals of survival benefit in randomized trials. Mechanistic evidence supports this paradigm, showing that the post‐infarct scar is dynamic and continues to remodel over time, with increasing arrhythmogenic complexity. The first ICD‐treated arrhythmia may therefore represent a biologically meaningful inflection point for intervention. Imaging and computational tools can refine patient selection and procedural planning after this trigger, while emerging ablation technologies may expand treatment options but do not modify timing strategies. Conclusions: A timing‐oriented approach to VT ablation, anchored to clinically meaningful ICD‐verified arrhythmic events, provides the most coherent integration of mechanistic insight and clinical evidence. This strategy may also have relevant implications for healthcare utilization, although formal cost‐effectiveness data remain limited. Future work should focus on refining patient selection within this therapeutic window and evaluating how evolving technologies can be integrated without compromising the central importance of timing.
- 2 June 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (7) , 1577-1587
Timing of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: Evidence, Mechanisms, and the Emerging Role of Timely ICD‐Guided Intervention
Background: The optimal timing of catheter ablation for ventricular tachycardia (VT) in ischemic cardiomyopathy remains uncertain, with strategies ranging from prophylactic intervention to delayed treatment after recurrent arrhythmia. Increasing evidence suggests that the timing of ablation may critically influence both arrhythmic and clinical outcomes. Objective: To synthesize contemporary evidence on VT ablation timing and to examine the mechanistic and clinical rationale supporting a timing‐oriented therapeutic framework. Methods: We performed a structured narrative review of randomized trials, observational studies, and mechanistic investigations evaluating different ablation strategies, including prophylactic, early, and ICD‐guided approaches. Particular emphasis was placed on integrating clinical outcomes with experimental and imaging data on post‐infarct substrate evolution. Results: Prophylactic ablation reduces arrhythmic burden but has not demonstrated consistent survival benefit. Early ablation strategies improve procedural outcomes but are limited by heterogeneous definitions and inconsistent prognostic impact. By contrast, a timely ICD‐guided approach—based on the first device‐verified arrhythmic event—has demonstrated consistent reductions in VT recurrence and ICD therapies, with emerging but heterogeneous signals of survival benefit in randomized trials. Mechanistic evidence supports this paradigm, showing that the post‐infarct scar is dynamic and continues to remodel over time, with increasing arrhythmogenic complexity. The first ICD‐treated arrhythmia may therefore represent a biologically meaningful inflection point for intervention. Imaging and computational tools can refine patient selection and procedural planning after this trigger, while emerging ablation technologies may expand treatment options but do not modify timing strategies. Conclusions: A timing‐oriented approach to VT ablation, anchored to clinically meaningful ICD‐verified arrhythmic events, provides the most coherent integration of mechanistic insight and clinical evidence. This strategy may also have relevant implications for healthcare utilization, although formal cost‐effectiveness data remain limited. Future work should focus on refining patient selection within this therapeutic window and evaluating how evolving technologies can be integrated without compromising the central importance of timing.
- Open Access
- 19 March 2025
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 10 (5) , 634-649
Delayed miR-199a Administration After Myocardial Infarction Precludes Pro-Regenerative Effects
- 19 March 2025
- Published by Elsevier in JACC: Basic To Translational Science
- Vol. 10 (5) , 634-649
Open AccessDelayed miR-199a Administration After Myocardial Infarction Precludes Pro-Regenerative Effects
- Open Access
- 1 February 2013
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 6 (1) , 101-107
Prevention of Syncope Through Permanent Cardiac Pacing in Patients With Bifascicular Block and Syncope of Unexplained Origin
Background—: Syncope in patients with bifascicular block (BFB) is a common event whose causes might be difficult to assess. Methods and Results—: Prevention of syncope through permanent cardiac pacing in patients with bifascicular block (PRESS) is a multicenter, prospective, randomized, single-blinded study designed to demonstrate a reduction in symptomatic events in patients with bifascicular block and syncope of undetermined origin implanted with permanent pacemaker. Device programming mode (NASPE/BPEG code) at DDD with a lower rate of 60 ppm is compared with backup pacing at DDI with a lower rate of 30 ppm. The end point consisted of (1) syncope, (2) symptomatic presyncopal episodes associated with a device intervention (ventricular pacing), and (3) symptomatic episodes associated with intermittent or permanent atrioventricular block (any degree). One hundred one patients were enrolled and randomized. Primary end point events at 2 years were observed in 23 patients, with a significant lower incidence in the study group (hazard ratio, 0.32; 95% confidence interval [CI], 0.10–0.96; P =0.042). Reduction of any symptoms, associated or not with device intervention, was superior in DDD60 compared with DDI30 (hazard ratio, 0.4; 95% confidence interval, 0.25–0.78; P =0.0053). Fourteen patients developed other rhythm diseases and met class I indication for pacing. The annual incidence of rhythm disease development was 7.4%. Conclusions—: In patients with bifascicular block and syncope of undetermined origin, the use of a dual chamber pacemaker programmed to DDD60 led to a significant reduction of syncope or symptomatic events associated with a cardioinhibitory origin, compared with DDI30 programming. Symptoms associated with a new onset of rhythm disease were found in 15% of the population at 2 years.
- 1 February 2013
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 6 (1) , 101-107
Open AccessPrevention of Syncope Through Permanent Cardiac Pacing in Patients With Bifascicular Block and Syncope of Unexplained Origin
Background—: Syncope in patients with bifascicular block (BFB) is a common event whose causes might be difficult to assess. Methods and Results—: Prevention of syncope through permanent cardiac pacing in patients with bifascicular block (PRESS) is a multicenter, prospective, randomized, single-blinded study designed to demonstrate a reduction in symptomatic events in patients with bifascicular block and syncope of undetermined origin implanted with permanent pacemaker. Device programming mode (NASPE/BPEG code) at DDD with a lower rate of 60 ppm is compared with backup pacing at DDI with a lower rate of 30 ppm. The end point consisted of (1) syncope, (2) symptomatic presyncopal episodes associated with a device intervention (ventricular pacing), and (3) symptomatic episodes associated with intermittent or permanent atrioventricular block (any degree). One hundred one patients were enrolled and randomized. Primary end point events at 2 years were observed in 23 patients, with a significant lower incidence in the study group (hazard ratio, 0.32; 95% confidence interval [CI], 0.10–0.96; P =0.042). Reduction of any symptoms, associated or not with device intervention, was superior in DDD60 compared with DDI30 (hazard ratio, 0.4; 95% confidence interval, 0.25–0.78; P =0.0053). Fourteen patients developed other rhythm diseases and met class I indication for pacing. The annual incidence of rhythm disease development was 7.4%. Conclusions—: In patients with bifascicular block and syncope of undetermined origin, the use of a dual chamber pacemaker programmed to DDD60 led to a significant reduction of syncope or symptomatic events associated with a cardioinhibitory origin, compared with DDI30 programming. Symptoms associated with a new onset of rhythm disease were found in 15% of the population at 2 years.
- 1 October 2009
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 10 (10) , 787-791
Role of electroanatomic mapping in assessing the extent of atrial standstill: diagnostic and therapeutic implications
Atrial standstill is characterized by failure of atrial excitation, either spontaneous or induced by atrial electric stimulation. We report the case of a 38-year-old man with severe bradycardia and junctional escape rhythm associated with dilative cardiomyopathy. Electroanatomic mapping showed the absence of atrial viability in almost the entire right atrial endocardial surface and excluded the feasibility of atrial pacing.
- 1 October 2009
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 10 (10) , 787-791
Role of electroanatomic mapping in assessing the extent of atrial standstill: diagnostic and therapeutic implications
Atrial standstill is characterized by failure of atrial excitation, either spontaneous or induced by atrial electric stimulation. We report the case of a 38-year-old man with severe bradycardia and junctional escape rhythm associated with dilative cardiomyopathy. Electroanatomic mapping showed the absence of atrial viability in almost the entire right atrial endocardial surface and excluded the feasibility of atrial pacing.
- 1 February 2008
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 9 (2) , 131-136
Effectiveness of cardiac resynchronisation therapy in patients with echocardiographic evidence of mechanical dyssynchrony
Cardiac resynchronisation therapy has proven to be effective in refractory heart failure (HF) patients with QRS >120-130 ms. Therefore, the aim of our study was to verify the long-term effectiveness of cardiac resynchronisation therapy in HF patients with echocardiographic evidence of mechanical asynchrony regardless of QRS duration. One hundred and six patients with New York Heart Association class II-IV HF and echocardiographic documentation of interventricular and intraventricular asynchrony underwent biventricular stimulation. A clinical and functional evaluation was performed at baseline, 1, 3, 6 months, and every 6 months thereafter. After a median follow-up of 16 months, a significant improvement was noted in ejection fraction, left ventricular diameters, mitral regurgitation jet area, interventricular and intraventricular echocardiographic indexes of asynchrony, and the 6-min walking distance (P < 0.001 for all). Death rates for all causes and for cardiac causes were 18.2 (95% confidence interval 12.8-25.9) and 13.5 (95% confidence interval 9.0-20.3) per 100 person-years, respectively. Patients in New York Heart Association class IV had an almost three-fold increase in risk of dying as compared to class II-III (hazard ratio 2.97, 95% confidence interval 1.30-6.79). Interventricular and intraventricular asynchrony at echocardiography may be useful in identifying HF patients suitable for cardiac resynchronisation therapy, with results comparable to those obtained with QRS duration selection criteria.
- 1 February 2008
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 9 (2) , 131-136
Effectiveness of cardiac resynchronisation therapy in patients with echocardiographic evidence of mechanical dyssynchrony
Cardiac resynchronisation therapy has proven to be effective in refractory heart failure (HF) patients with QRS >120-130 ms. Therefore, the aim of our study was to verify the long-term effectiveness of cardiac resynchronisation therapy in HF patients with echocardiographic evidence of mechanical asynchrony regardless of QRS duration. One hundred and six patients with New York Heart Association class II-IV HF and echocardiographic documentation of interventricular and intraventricular asynchrony underwent biventricular stimulation. A clinical and functional evaluation was performed at baseline, 1, 3, 6 months, and every 6 months thereafter. After a median follow-up of 16 months, a significant improvement was noted in ejection fraction, left ventricular diameters, mitral regurgitation jet area, interventricular and intraventricular echocardiographic indexes of asynchrony, and the 6-min walking distance (P < 0.001 for all). Death rates for all causes and for cardiac causes were 18.2 (95% confidence interval 12.8-25.9) and 13.5 (95% confidence interval 9.0-20.3) per 100 person-years, respectively. Patients in New York Heart Association class IV had an almost three-fold increase in risk of dying as compared to class II-III (hazard ratio 2.97, 95% confidence interval 1.30-6.79). Interventricular and intraventricular asynchrony at echocardiography may be useful in identifying HF patients suitable for cardiac resynchronisation therapy, with results comparable to those obtained with QRS duration selection criteria.
- 29 October 2007
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 30 (11) , 1349-1355
Cardiac Resynchronization Therapy:
Aim: Gender related differences in epidemiology, treatment, and prognosis of heart failure (HF) have been reported. We examined the sex influence in patients treated with cardiac resynchronization therapy (CRT). Methods and Results: Out of 334 consecutive HF patients (19.7% women) who underwent CRT, 195 patients reached clinical and echocardiographic evaluation at six and 12 months and were selected for analysis. A reduction in left ventricular (LV) end‐diastolic volume/m2 (EDVi) and end systolic volume/m2 (ESVi) was evident in the overall population at six months (P < 0.001) and from six to 12 months (P < 0.001). Compared to men, women showed significantly greater changes in LV volumes at mid (P < 0.05) and long‐term (P < 0.001) follow‐up and a significantly higher LV ejection fraction (EF) (40.8 ± 12.3 vs 34.1 ± 10.1, P < 0.01) at one year. Multiple regression analysis, including several demographic and clinical parameters, revealed that female gender is independently associated with greater reduction in LV ESVi. At the 12‐month follow‐up, the proportion of responders (defined in terms of ESV reduction by at least 10%) was higher in women than in men (76.1% vs 59.3%, P < 0.05). Conclusions: CRT induced a gender specific LV remodeling response.
- 29 October 2007
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 30 (11) , 1349-1355
Cardiac Resynchronization Therapy:
Aim: Gender related differences in epidemiology, treatment, and prognosis of heart failure (HF) have been reported. We examined the sex influence in patients treated with cardiac resynchronization therapy (CRT). Methods and Results: Out of 334 consecutive HF patients (19.7% women) who underwent CRT, 195 patients reached clinical and echocardiographic evaluation at six and 12 months and were selected for analysis. A reduction in left ventricular (LV) end‐diastolic volume/m2 (EDVi) and end systolic volume/m2 (ESVi) was evident in the overall population at six months (P < 0.001) and from six to 12 months (P < 0.001). Compared to men, women showed significantly greater changes in LV volumes at mid (P < 0.05) and long‐term (P < 0.001) follow‐up and a significantly higher LV ejection fraction (EF) (40.8 ± 12.3 vs 34.1 ± 10.1, P < 0.01) at one year. Multiple regression analysis, including several demographic and clinical parameters, revealed that female gender is independently associated with greater reduction in LV ESVi. At the 12‐month follow‐up, the proportion of responders (defined in terms of ESV reduction by at least 10%) was higher in women than in men (76.1% vs 59.3%, P < 0.05). Conclusions: CRT induced a gender specific LV remodeling response.
- Open Access
- 17 July 2007
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 9 (9) , 732-738
Efficacy of cardiac resynchronization therapy in very old patients: the Insync/Insync ICD Italian Registry
Aims To assess the effects of cardiac resynchronization therapy (CRT) in ≥80-year-old patients vs. patients Methods and results The study population consisted of 1181 CRT patients (85 were ≥80 years old). They were enrolled in a national observational registry and underwent baseline evaluation and periodical follow-up visits. In the overall population, New York Heart Association class and ejection fraction (EF) improved and ventricular diameters decreased. Similar changes were observed in the two groups. In the study population, 157 patients died, 144 (13%) in the P = 0.015) among ≥80 years patients, with a trend towards higher sudden cardiac death (SCD) ( P = 0.057), but similar non-SCD ( P = 0.293). Using the combined endpoint of SCD or appropriate shock from a defibrillator for ventricular fibrillation, no significant differences resulted between groups ( P = 0.455). In both groups, lower EF was associated with higher mortality. Conclusion Cardiac resynchronization therapy demonstrated similar efficacy in patients aged ≥80 years and in those under 80, in terms of clinical and functional parameters and reverse remodelling. Similarly, CRT resulted in comparable effects on death for heart failure and on SCD.
- 17 July 2007
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 9 (9) , 732-738
Open AccessEfficacy of cardiac resynchronization therapy in very old patients: the Insync/Insync ICD Italian Registry
Aims To assess the effects of cardiac resynchronization therapy (CRT) in ≥80-year-old patients vs. patients Methods and results The study population consisted of 1181 CRT patients (85 were ≥80 years old). They were enrolled in a national observational registry and underwent baseline evaluation and periodical follow-up visits. In the overall population, New York Heart Association class and ejection fraction (EF) improved and ventricular diameters decreased. Similar changes were observed in the two groups. In the study population, 157 patients died, 144 (13%) in the P = 0.015) among ≥80 years patients, with a trend towards higher sudden cardiac death (SCD) ( P = 0.057), but similar non-SCD ( P = 0.293). Using the combined endpoint of SCD or appropriate shock from a defibrillator for ventricular fibrillation, no significant differences resulted between groups ( P = 0.455). In both groups, lower EF was associated with higher mortality. Conclusion Cardiac resynchronization therapy demonstrated similar efficacy in patients aged ≥80 years and in those under 80, in terms of clinical and functional parameters and reverse remodelling. Similarly, CRT resulted in comparable effects on death for heart failure and on SCD.
- 31 May 2006
- Published by Elsevier in Heart Rhythm
- Vol. 3 (5) , S336-336
P6-104: Gender differences in long term outcome of cardiac resynchronization therapy
- 31 May 2006
- Published by Elsevier in Heart Rhythm
- Vol. 3 (5) , S336-336
P6-104: Gender differences in long term outcome of cardiac resynchronization therapy